Synucleozid-2.0 is a blood-brain barrier-permeable inhibitor that binds to the IRE of SNCA mRNA, with a EC50 of 2.9 µM and a Kd value of 1.8 µM. Synucleozid-2.0 selectively binds to and stabilizes the A bulge and adjacent closed base pairs in the 5 UTR IRE of SNCA mRNA, blocks the translation process and reduces intracellular levels of alpha-synuclein. Synucleozid-2.0 exerts cytoprotective effects against cytotoxicity induced by alpha-synuclein preformed fibrils. Synucleozid-2.0 is applicable to the research of Parkinsons disease[1].
Molecular Weight:
506.38
CAS Number:
[613226-91-8]
Formula:
C22H16BrN7OS
Target:
DNA/RNA Synthesis,alpha-synuclein
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted